Anshita Goel is interested in application of next-generation sequencing technologies towards understanding how changes in genetic sequence across cell types or population cohorts, can be used to understand human health and disease. At present she applies high-throughput algorithms on clinical datasets to decipher somatic mutations that may be attributable to tumour aetiology or treatment response.